Current price is more than the intrinsic value

Intrinsic Value

Stock has been generating better return on equity than bank FD

ROE vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

All four brands are focused on the paediatric segment in the country with a total covered market size of Rs 1,800 crore as per IQVIA data, JB Chemicals & Pharmaceuticals said.

JB Chemicals’ board approves to acquire Dr Reddy’s 4 brands

All four brands are focused on the paediatric segment in India with a total market size of Rs 1,800 crore.

JB Chemicals Gets Board Approval To Acquire Four Brands Of Dr Reddy’s

JB Chemicals & Pharmaceuticals on Thursday said its board has approved a proposal to acquire four paediatric brands from Dr Reddy’s Laboratories for about Rs 98 crore

JB Chem gets board approval to acquire Dr Reddy’s 4 brands for Rs 98 cr

JB Chemicals Management Meet Update: Nirmal Bang

JB Chemicals said its rank in the domestic pharma market improved to 25 from 32 in the last 12 months.

JB Chemicals Offers Upbeat Margin Guidance Amid Caution All Around

Dr Reddy’s Laboratories is also understood to have made to the penultimate round of bidding process, people with direct knowledge of the matter told ET. The transaction will see the exit of existing investors such as ChrysCapital and Sequoia Capital. Promoters are expected to stay on with a minority…

Torrent Pharma, JB Chemicals in final race to acquire Curatio Healthcare

JB Chemicals now plan to enter new areas like sleep disorders, sexual wellness, motion sickness, and immunity apart, from the conventional areas like cough, sore throat, etc.

KKR-backed JB Chemicals bets big on lozenges and probiotic products

JB Chemicals Q3 Review - Continuously Outpacing Domestic Growth: ICICI Securities

JB Chemicals Consolidated December 2021 Net Sales at Rs 600.66 crore, up 9.57% Y-o-Y

JB Chemicals - Foray Into Nutraceuticals, Probiotics: ICICI Securities

JB Chemicals and Pharmaceuticals Ltd on Thursday said it will acquire brands for the Indian market from Sanzyme Pvt Ltd, a player in the probiotics and reproductive health segment, for Rs 628 crore. The brands to be acquired include those in the probiotics portfolio and reproductive health segment o…

JB Chemicals to acquire brands from Sanzyme for Rs 628 crore

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets a range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredient (APIs).

J B Chemicals and Pharmaceuticals Ltd

J B Chemicals and Pharmaceuticals Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

JB Chemicals’ board approves to acquire Dr Reddy’s 4 brands

JB Chemicals Gets Board Approval To Acquire Four Brands Of Dr Reddy’s

JB Chem gets board approval to acquire Dr Reddy’s 4 brands for Rs 98 cr

JB Chemicals Management Meet Update: Nirmal Bang

JB Chemicals Offers Upbeat Margin Guidance Amid Caution All Around

Torrent Pharma, JB Chemicals in final race to acquire Curatio Healthcare

KKR-backed JB Chemicals bets big on lozenges and probiotic products

J B Chemicals and Pharmaceuticals Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

JB Chemicals’ board approves to acquire Dr Reddy’s 4 brands

JB Chemicals Gets Board Approval To Acquire Four Brands Of Dr Reddy’s

JB Chem gets board approval to acquire Dr Reddy’s 4 brands for Rs 98 cr

JB Chemicals Management Meet Update: Nirmal Bang

JB Chemicals Offers Upbeat Margin Guidance Amid Caution All Around

Torrent Pharma, JB Chemicals in final race to acquire Curatio Healthcare

KKR-backed JB Chemicals bets big on lozenges and probiotic products

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock